Chronic thromboembolic pulmonary hypertension
…, M De Perrot, J Cerrina, FL Ladurie… - European …, 2004 - Eur Respiratory Soc
Pulmonary arterial hypertension is a severe disease that has been ignored for a long time.
However, over the past 20 yrs chest physicians, cardiologists and thoracic surgeons have …
However, over the past 20 yrs chest physicians, cardiologists and thoracic surgeons have …
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
…, A Tarhini, E Routier, O Lambotte, FL Ladurie… - Nature reviews Clinical …, 2016 - nature.com
Inhibition of immune checkpoints using anti-programmed cell death-1 (PD-1) or anti
cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibodies has revolutionized …
cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibodies has revolutionized …
Is sacrifying the phrenic nerve during thymoma resection worthwhile?
…, B Besse, C Le Pechoux, FL Ladurie… - European Journal of …, 2014 - academic.oup.com
OBJECTIVES Locally advanced thymoma can often involve the phrenic nerve (PN) due to its
location on the mediastinal pleura. However, en bloc resection including the PN may cause …
location on the mediastinal pleura. However, en bloc resection including the PN may cause …
Traitement chirurgical de la maladie thromboembolique pulmonaire chronique
…, E Fadel, S Mussot, J Cerrina, FL Ladurie… - La Presse Médicale, 2005 - Elsevier
Points essentiels ● La maladie thrombo-embolique pulmonaire chronique est une affection
grave, restée longtemps dans l’ombre au rang de maladie orpheline en raison de l’absence …
grave, restée longtemps dans l’ombre au rang de maladie orpheline en raison de l’absence …
Modulation of ICAM-1 expression in human alveolar macrophages in vitro
M Fattal-German, FL Ladurie, J Cerrina… - European …, 1996 - Eur Respiratory Soc
Modulation of intercellular adhesion molecule-1 (ICAM-1) expression may be a basic mechanism
by which alveolar macrophages (AMs) regulate the inflammatory process in the lung in …
by which alveolar macrophages (AMs) regulate the inflammatory process in the lung in …
Comparison of cardiac allograft vasculopathy in heart and heart–lung transplantations: A 15-year retrospective study
…, M Aymami, S Fattal, C Chabanne, FL Ladurie… - The Journal of Heart and …, 2014 - Elsevier
Background Cardiac allograft vasculopathy (CAV) is a major factor limiting long-term survival
after heart transplantation (HTx). Specific determinants of CAV and long-term outcome after …
after heart transplantation (HTx). Specific determinants of CAV and long-term outcome after …
Surgical treatment of chronic thromboembolic pulmonary hypertension
3. Assistance publique-Hôpitaux de Paris, hôpital Kremlin-Bicêtre, université Paris-sud,
centre de référence national des maladies vasculaires pulmonaires, service de …
centre de référence national des maladies vasculaires pulmonaires, service de …
Respiratory sensation related to resistive loads in lung transplant recipients.
C Peiffer, D Silbert, J Cerrina, FL Ladurie… - American journal of …, 1996 - atsjournals.org
In order to assess the contribution of pulmonary afferent nerves to the processing of respiratory
sensation, we compared sensation related to inspiratory resistive loaded breathing in 14 …
sensation, we compared sensation related to inspiratory resistive loaded breathing in 14 …
Anesthesia and intensive care for heart-lung transplantation
…, M Weiss, F Nicolas, JP Duffet, FL Ladurie… - Annales Francaises D …, 1991 - europepmc.org
Since Shumway carried out the first successful heart-lung transplant (HLT) in Stanford in
1981, HLT has become a new therapeutic means for patients with end-stage pulmonary …
1981, HLT has become a new therapeutic means for patients with end-stage pulmonary …
Detailed safety profile of the anti-PD-1 monoclonal antibody pembrolizumab in 78 consecutive patients (pts) with advanced melanoma
…, S Roy, E Lanoy, J Le Pavec, FL Ladurie… - Annals of …, 2016 - annalsofoncology.org
Background The programmed death receptor 1 (PD-1) inhibitor pembrolizumab has shown
clinical benefit with acceptable tolerability in pts with advanced melanoma. We provide …
clinical benefit with acceptable tolerability in pts with advanced melanoma. We provide …